# A Study of Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected Patients

> **NCT01638650** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 23 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Nucleoside Reverse Transcriptase Inhibitor (NRTIs)
- **DRUG:** ritonavir
- **DRUG:** saquinavir [Invirase]

## Key facts

- **NCT ID:** NCT01638650
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01638650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01638650, "A Study of Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01638650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*